Ascentage Pharma to Present Five Preclinical Studies from Innovative Pipeline at American Association of Cancer Research (AACR) Annual Meeting 2025
The data to be presented encompasses five of the company’s novel drug candidates: BCR-ABL tyrosine kinase inhibitor olverembatinib (HQP1351), Bcl-2 inhibitor lisaftoclax (APG-2575), FAK/ALK/ROS1 ...
Why hundreds of Aussies are lining up for the chance to try a $3 snack
Many Aussies were similarly excited. 'I'm never ordering anything else while at university,' one excited fan wrote. 'Oh my ...